Although our study suggests that DLL3 may have a relatively small impact on the survival of SCLC patients based on our data, interestingly, patients with 100% DLL3-high expression and PDL1 expression >1% seem to have better survival. This evidence concerns the gene DLL3 and small cell lung carcinoma.